FFO
BVS icon

Fortitude Family Office’s Bioventus BVS Stock Holding History

Fortitude Family Office’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$55 Hold
4
– – ﹤0.01% 2579
2026
Q2 		$38 Buy
+4
New +$38 ﹤0.01% 2222
2025
Q2 		– Sell
-81
Closed -$741 – 2041
2025
Q1 		$741 Hold
81
– – ﹤0.01% 1053
2024
Q4 		$851 Buy
+81
New +$958 ﹤0.01% 1156

Other funds holding BVS

Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
ATC
Adirondack Trust Company Saratoga Springs, New York $320M AUM 23.25% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Fortitude Family Office's BVS Position: Q3 2026 in Review

Fortitude Family Office held its Bioventus (BVS) position steady in Q3 2026 at 4 shares worth $55. The position accounts for ﹤0.01% of the portfolio, ranked #2579.

Fortitude Family Office first reported a position in BVS in Q4 2024 and has held it in 4 quarters since. The position peaked at $851 in Q4 2024. 9 funds tracked by Wall St. Rank hold BVS as of Q3 2026.

  • Fortitude Family Office held 4 shares of Bioventus worth $55 as of Q3 2026.
  • Fortitude Family Office left its Bioventus share count unchanged in Q3 2026.
  • Bioventus made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #2579 holding.
  • Fortitude Family Office first reported a position in Bioventus in Q4 2024 and has held it in 4 quarters since.
  • Fortitude Family Office's Bioventus position peaked at $851 in Q4 2024.
  • 9 funds tracked by Wall St. Rank held Bioventus as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.